(Q37950596)

25 August 2017

1 reference

title

Clinical pharmacokinetics of the newer ACE inhibitors. A review (English)

1 reference

25 August 2017

1 reference

Kelly JG

1

1 reference

25 August 2017

O'Malley K

series ordinal

2

1 reference

25 August 2017

language of work or name

1 reference

1 September 1990

1 reference

Clinical Pharmacokinetics

25 August 2017

published in

1 reference

25 August 2017

volume

19

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

177-196

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199019030-00003

25 August 2017

exact match

0 references

cites work

Determination of the angiotensin converting enzyme inhibitor benazeprilat in plasma and urine by an enzymic method

1 reference

12 December 2020

Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function

1 reference

12 December 2020

Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (delapril) in patients with deteriorated kidney function and in normal control subjects

1 reference

12 December 2020

Inhibition of renal clearance of furosemide by pentopril, an angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

The clinical pharmacokinetics of quinapril

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

1 reference

12 December 2020

Pharmacokinetics of intravenous cilazaprilat in normal volunteers

1 reference

12 December 2020

Determination of a new angiotensin converting enzyme inhibitor (CV-3317) and its metabolites in serum and urine by high-performance liquid chromatography

1 reference

12 December 2020

A study of the potential pharmacokinetic interaction of lisinopril and digoxin in normal volunteers.

1 reference

12 December 2020

CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteers

1 reference

12 December 2020

Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.

1 reference

12 December 2020

Pharmacologic, metabolic, and toxicologic profile of spirapril (SCH 33844), a new angiotensin converting inhibitor.

1 reference

12 December 2020

Pharmacokinetics of lisinopril (MK521) in healthy young and elderly subjects and in elderly patients with cardiac failure

1 reference

12 December 2020

Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors: measurement of relative inhibitory potency and serum drug levels by radioinhibitor binding displacement assay

1 reference

12 December 2020

Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review

1 reference

12 December 2020

Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model

1 reference

12 December 2020

The physiological disposition and metabolism of enalapril maleate in laboratory animals

1 reference

12 December 2020

Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril.HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration

1 reference

12 December 2020

Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (alacepril) after oral dosing in fasting or fed states.

1 reference

12 December 2020

Pharmacokinetics of perindopril: therapeutic consequences

1 reference

12 December 2020

A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA

1 reference

12 December 2020

Pharmacokinetics and acute effect on the renin-angiotensin system of delapril in patients with chronic renal failure.

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis

1 reference

12 December 2020

Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers

1 reference

12 December 2020

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

1 reference

12 December 2020

Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology

1 reference

12 December 2020

Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex

1 reference

12 December 2020

Pharmacokinetics and effects on the renin-angiotensin system of ramipril in elderly patients

1 reference

12 December 2020

Influence of renal function on the pharmacokinetics of ramipril (HOE 498)

1 reference

12 December 2020

Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers

1 reference

12 December 2020

Enalapril maleate and a lysine analogue (MK-521): disposition in man

1 reference

12 December 2020

Disposition of fosinopril sodium in healthy subjects

1 reference

12 December 2020

Conversion of angiotensin I to angiotensin II.

1 reference

12 December 2020

Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers

1 reference

12 December 2020

Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

Determination of captopril in human blood by high-performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis

1 reference

12 December 2020

Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects

1 reference

12 December 2020

The pharmacokinetics and dose proportionality of cilazapril

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations

1 reference

12 December 2020

Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine

1 reference

12 December 2020

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

1 reference

12 December 2020

The role of the renin-angiotensin system in blood pressure regulation in normotensive animals and man

1 reference

12 December 2020

Simultaneous determination of the prodrug zofenopril and its active drug in plasma by capillary gas chromatography-mass-selective detection

1 reference

12 December 2020

Combined gas chromatographic-mass spectrometric procedure for the measurement of captopril and sulfur-conjugated metabolites of captopril in plasma and urine

1 reference

12 December 2020

Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.

1 reference

12 December 2020

SQ 27,786 and SQ 28,853: two angiotensin converting enzyme inhibitors with potent diuretic activity

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humans.

1 reference

12 December 2020

The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients

1 reference

12 December 2020

A pharmacokinetic study of cilazapril in elderly and young volunteers

1 reference

12 December 2020

Effect of food on the bioavailability of lisinopril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.

1 reference

12 December 2020

Effect of renal impairment on disposition of pentopril and its active metabolite

1 reference

12 December 2020

High-performance liquid chromatographic analysis of captopril in plasma

1 reference

12 December 2020

Determination of quinapril and its active metabolite in human plasma and urine by gas chromatography with electron-capture detection

1 reference

12 December 2020

Enzyme immunoassay discrimination of a new angiotensin-converting enzyme (ACE) inhibitor, cilazapril, and its active metabolite

1 reference

12 December 2020

A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor

1 reference

12 December 2020

A radioimmunoassay for MC-838 (altiopril calcium), a novel angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics

1 reference

12 December 2020

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

1 reference

12 December 2020

Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV).

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of ramipril in renal failure

1 reference

12 December 2020

Chemical design of cilazapril

1 reference

12 December 2020

Quantitative Determination of Captopril in Blood and Captopril and Its Disulfide Metabolites in Plasma by Gas Chromatography

1 reference

12 December 2020

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521

1 reference

12 December 2020

Pharmacokinetics of repeated single oral doses of enalapril maleate (mk-421) in normal volunteers

1 reference

12 December 2020

Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo

1 reference

12 December 2020

A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man

1 reference

12 December 2020

Gas chromatography-mass spectrometry of perindopril and its active free metabolite, an angiotensin convertase inhibitor: choice of derivatives and ionization modes

1 reference

12 December 2020

Influence of age on the pharmacokinetics and pharmacodynamics of perindopril

1 reference

12 December 2020

Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man

1 reference

12 December 2020

Pharmacokinetics of lisinopril (IV/PO) in healthy volunteers

1 reference

12 December 2020

Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.

1 reference

12 December 2020

Enzyme immunoassay for captopril

1 reference

12 December 2020

Pharmacokinetics of ramipril in the elderly

1 reference

12 December 2020

Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity

1 reference

12 December 2020

Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril

1 reference

12 December 2020

Determination of captopril and its mixed disulphides in plasma and urine by high-performance liquid chromatography

1 reference

12 December 2020

2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin I converting enzyme inhibitor

1 reference

12 December 2020

A pharmacokinetic study of cilazapril in patients with congestive heart failure

1 reference

12 December 2020

Liquid-chromatographic determination of an angiotensin converting enzyme inhibitor, CGS 13945, and its active metabolite (CGS 13934) in plasma

1 reference

12 December 2020

Multiple-dose cimetidine administration does not influence the single-dose pharmacokinetics of quinapril and its active metabolite (CI-928)

1 reference

12 December 2020

Pharmacokinetic interaction study with ramipril and digoxin in healthy volunteers

1 reference

12 December 2020

The influence of food on the pharmacokinetics and ACE inhibition of cilazapril

1 reference

12 December 2020

Lisinopril population pharmacokinetics in elderly and renal disease patients with hypertension

1 reference

12 December 2020

Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.

1 reference

12 December 2020

The pharmacokinetics and bioavailability of cilazapril in normal man.

1 reference

12 December 2020

MC-838 (altiopril calcium): a novel orally active angiotensin converting enzyme inhibitor

1 reference

12 December 2020

Pharmacokinetics and depressor effect of delapril in patients with essential hypertension

1 reference

12 December 2020

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

1 reference

12 December 2020

Competitive inhibitor binding assay (CIBA) of ACE inhibitors

1 reference

12 December 2020

Pharmacokinetics of pentopril in the elderly

1 reference

12 December 2020

Development and optimisation of a radioimmunoassay for plasma captopril

1 reference

12 December 2020

Pentopril-Cimetidine Interaction Caused by a Reduction in Hepatic Blood Flow

1 reference

12 December 2020

A radioimmunoassay for the angiotensin converting enzyme inhibitor ramipril and its active metabolite

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics of enalapril in normal subjects and patients with renal impairment

1 reference

12 December 2020

Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril

1 reference

12 December 2020

Pharmacological interferences with the renin-angiotensin system.

1 reference

12 December 2020

Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers.

1 reference

12 December 2020

Direct determination of angiotensin-converting enzyme inhibitors in plasma by radioenzymatic assay

1 reference

12 December 2020

Lisinopril in hypertensive patients with and without renal failure.

1 reference

12 December 2020

10.2165/00003088-199019030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

25 August 2017

1021194742

0 references

1 reference